Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited Standalone and ....

Date: July 28, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Scrip Code: 541096 Dear Sir/Madam, Subject: Intimation of Board Meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, August 05, 2026 at the registered office of the company to consider, approve and take on record the Unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2026. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and its immediate relatives, the Trading Window for dealing in securities of the company for all the Designated persons has already been closed with effect from Wednesday, July 01, 2026 till Forty-eight (48) hours after the declaration of the said financial results of the company. The notice is also available on the website of the Company at www.bplindia.in You are requested to take the same on record. Thanking You, For, Bharat Parenterals Limited Mr. Sharmin Soni Company Secretary & Compliance Officer ICSI Membership No: A-75694 Place: Vadodara